ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Urban Lönn
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peterzén, B.
Right arrow Articles by Rutberg, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peterzén, B.
Right arrow Articles by Rutberg, H.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;62:495-500
© 1996 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Postoperative Management of Patients With Hemopump Support After Coronary Artery Bypass Grafting

Bengt Peterzén, MD, Urban Lönn, MD, Ankica Babic, PhD, Hans Granfeldt, MD, Henrik Casimir-Ahn, MD, PhD, Hans Rutberg, MD, PhD

Linköping Heart Center and Department of Medical Informatics, University of Linköping, Linköping, Sweden

Accepted for publication March 15, 1996.

Background. In this study, we describe postoperative monitoring, pharmacologic therapy, and hemodynamic responses in patients receiving Hemopump support after postcardiotomy heart failure.

Methods. The Hemopump was used in 24 patients with severe left ventricular dysfunction after coronary artery bypass grafting.

Results. Fourteen patients (58%) were weaned from the Hemopump. Low to moderate doses of a combination of catecholamines, phosphodiesterase inhibitors, vasodilators, and vasoconstrictors were required to optimize Hemopump function and left ventricular unloading. Mean arterial blood pressure, mixed venous oxygen saturation, and urinary output were the most important therapy guidelines.

Conclusions. Together with our clinical protocol, the Hemopump effectively unloaded the failing ventricle while maintaining vital-organ perfusion. Doses of vasoactive drugs could be kept low. This approach to treatment provides good conditions for recovery of the stunned myocardium.


Related Article

Invited Commentary
Bart P. Meyns, Paul T. Sergeant, Willem J. Daenen, and Willem J. Flameng
Ann. Thorac. Surg. 1996 62: 500. [Extract] [Full Text]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
N. Doll, B. Kiaii, M. Borger, J. Bucerius, K. Kramer, D. V. Schmitt, T. Walther, and F. W. Mohr
Five-Year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock
Ann. Thorac. Surg., January 1, 2004; 77(1): 151 - 157.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
D. J Duncker, R. Schulz, R. Ferrari, D. Garcia-Dorado, C. Guarnieri, G. Heusch, and P. D Verdouw
"Myocardial stunning": remaining questions
Cardiovasc Res, June 1, 1998; 38(3): 549 - 558.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. J. DeRose Jr, J. P. Umana, M. Argenziano, K. A. Catanese, H. R. Levin, B. C. Sun, E. A. Rose, and M. C. Oz
Improved Results for Postcardiotomy Cardiogenic Shock With the Use of Implantable Left Ventricular Assist Devices
Ann. Thorac. Surg., December 1, 1997; 64(6): 1757 - 1762.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.